These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 16497273

  • 1. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
    Poyurovsky M, Pashinian A, Weizman R, Fuchs C, Weizman A.
    Biol Psychiatry; 2006 Jun 01; 59(11):1071-7. PubMed ID: 16497273
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
    Poyurovsky M, Epshtein S, Fuchs C, Schneidman M, Weizman R, Weizman A.
    J Clin Psychopharmacol; 2003 Jun 01; 23(3):305-8. PubMed ID: 12826992
    [Abstract] [Full Text] [Related]

  • 3. Role of mirtazapine in the treatment of antipsychotic-induced akathisia.
    Hieber R, Dellenbaugh T, Nelson LA.
    Ann Pharmacother; 2008 Jun 01; 42(6):841-6. PubMed ID: 18460588
    [Abstract] [Full Text] [Related]

  • 4. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J, Barkin RL.
    J Clin Psychiatry; 1998 Mar 01; 59(3):123-7. PubMed ID: 9541155
    [Abstract] [Full Text] [Related]

  • 5. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
    Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN.
    J Clin Psychiatry; 2005 Apr 01; 66(4):515-20. PubMed ID: 15816795
    [Abstract] [Full Text] [Related]

  • 6. The effect of mirtazapine in patients with chronic pain and concomitant depression.
    Freynhagen R, Muth-Selbach U, Lipfert P, Stevens MF, Zacharowski K, Tölle TR, von Giesen HJ.
    Curr Med Res Opin; 2006 Feb 01; 22(2):257-64. PubMed ID: 16466597
    [Abstract] [Full Text] [Related]

  • 7. Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
    Berk M, Gama CS, Sundram S, Hustig H, Koopowitz L, D'Souza R, Malloy H, Rowland C, Monkhouse A, Monkhouse A, Bole F, Sathiyamoorthy S, Piskulic D, Dodd S.
    Hum Psychopharmacol; 2009 Apr 01; 24(3):233-8. PubMed ID: 19330802
    [Abstract] [Full Text] [Related]

  • 8. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
    Schüle C, Baghai TC, Eser D, Hecht S, Hermisson I, Born C, Häfner S, Nothdurfter C, Rupprecht R.
    World J Biol Psychiatry; 2007 Apr 01; 8(2):112-22. PubMed ID: 17455104
    [Abstract] [Full Text] [Related]

  • 9. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J, MIND-IT investigators.
    Psychosom Med; 2007 Apr 01; 69(7):606-13. PubMed ID: 17846258
    [Abstract] [Full Text] [Related]

  • 10. The effectiveness of intramuscular biperiden in acute akathisia: a double-blind, randomized, placebo-controlled study.
    Baskak B, Atbasoglu EC, Ozguven HD, Saka MC, Gogus AK.
    J Clin Psychopharmacol; 2007 Jun 01; 27(3):289-94. PubMed ID: 17502777
    [Abstract] [Full Text] [Related]

  • 11. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD, Kundhur D, Solomons K, Yatham LN, Lam RW.
    J Psychiatry Neurosci; 2003 Jan 01; 28(1):55-9. PubMed ID: 12587851
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A, Crawford GM, Angus M, Wilson R, Hamilton L.
    Int Clin Psychopharmacol; 2003 May 01; 18(3):133-41. PubMed ID: 12702891
    [Abstract] [Full Text] [Related]

  • 13. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.
    Curr Med Res Opin; 2007 Jun 01; 23(6):1303-18. PubMed ID: 17559729
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 01; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
    Altintoprak AE, Zorlu N, Coskunol H, Akdeniz F, Kitapcioglu G.
    Hum Psychopharmacol; 2008 Jun 01; 23(4):313-9. PubMed ID: 18327889
    [Abstract] [Full Text] [Related]

  • 16. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.
    Eur Neuropsychopharmacol; 2009 Jul 01; 19(7):457-65. PubMed ID: 19345072
    [Abstract] [Full Text] [Related]

  • 17. Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia.
    Poyurovsky M, Bergman J, Pashinian A, Weizman A.
    Int Clin Psychopharmacol; 2014 Sep 01; 29(5):296-8. PubMed ID: 24667488
    [Abstract] [Full Text] [Related]

  • 18. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA, Brecher M, Paulsson B.
    Bipolar Disord; 2006 Oct 01; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [Abstract] [Full Text] [Related]

  • 19. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
    Cruickshank CC, Montebello ME, Dyer KR, Quigley A, Blaszczyk J, Tomkins S, Shand D.
    Drug Alcohol Rev; 2008 May 01; 27(3):326-33. PubMed ID: 18368615
    [Abstract] [Full Text] [Related]

  • 20. Akathisia induced by mirtazapine after 20 years of continuous treatment.
    Markoula S, Konitsiotis S, Chatzistefanidis D, Lagos G, Kyritsis AP.
    Clin Neuropharmacol; 2010 May 01; 33(1):50-1. PubMed ID: 20124786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.